Suppr超能文献

泛素样修饰因子化在健康与疾病中的多方面作用。

Multifaceted roles of UFMylation in health and disease.

作者信息

Wang Ru-Na, Li Lin, Zhou Jun, Ran Jie

机构信息

Center for Cell Structure and Function, Shandong Provincial Key Laboratory of Animal Resistance Biology, College of Life Sciences, Shandong Normal University, Jinan, 250014, China.

Department of Genetics and Cell Biology, College of Life Sciences, State Key Laboratory of Medicinal Chemical Biology, Haihe Laboratory of Cell Ecosystem, Nankai University, Tianjin, 300071, China.

出版信息

Acta Pharmacol Sin. 2025 Apr;46(4):805-815. doi: 10.1038/s41401-024-01456-9. Epub 2025 Jan 7.

Abstract

Ubiquitin fold modifier 1 (UFM1) is a newly identified post-translational modifier that is involved in the UFMylation process. Similar to ubiquitination, UFMylation enables the conjugation of UFM1 to specific target proteins, thus altering their stability, activity, or localization. UFM1 chains have the potential to undergo cleavage from their associated proteins via UFM1-specific proteases, thus highlighting a reversible feature of UFMylation. This modification is conserved across nearly all eukaryotic organisms, and is associated with diverse biological activities such as hematopoiesis and the endoplasmic reticulum stress response. The disruption of UFMylation results in embryonic lethality in mice and is associated with various human diseases, thus underscoring its essential role in embryonic development, tissue morphogenesis, and organismal homeostasis. In this review, we aim to provide an in-depth overview of the UFMylation system, its importance in disease processes, and its potential as a novel target for therapeutic intervention.

摘要

泛素折叠修饰因子1(UFM1)是一种新发现的参与UFMylation过程的翻译后修饰因子。与泛素化类似,UFMylation使得UFM1与特定靶蛋白结合,从而改变其稳定性、活性或定位。UFM1链有可能通过UFM1特异性蛋白酶从其相关蛋白上裂解下来,这突出了UFMylation的可逆特性。这种修饰在几乎所有真核生物中都是保守的,并且与造血作用和内质网应激反应等多种生物学活性相关。UFMylation的破坏会导致小鼠胚胎致死,并与多种人类疾病相关,从而强调了其在胚胎发育、组织形态发生和机体稳态中的重要作用。在这篇综述中,我们旨在深入概述UFMylation系统、其在疾病过程中的重要性以及作为治疗干预新靶点的潜力。

相似文献

1
Multifaceted roles of UFMylation in health and disease.
Acta Pharmacol Sin. 2025 Apr;46(4):805-815. doi: 10.1038/s41401-024-01456-9. Epub 2025 Jan 7.
2
UFMylation: A Potential Modification for Neurological Diseases.
Curr Neuropharmacol. 2025;23(8):907-917. doi: 10.2174/011570159X340639240905092813.
3
The UFM1 E3 ligase recognizes and releases 60S ribosomes from ER translocons.
Nature. 2024 Mar;627(8003):437-444. doi: 10.1038/s41586-024-07093-w. Epub 2024 Feb 21.
5
The Epstein-Barr virus deubiquitinase BPLF1 regulates stress-induced ribosome UFMylation and reticulophagy.
Autophagy. 2025 May;21(5):996-1018. doi: 10.1080/15548627.2024.2440846. Epub 2025 Jan 22.
6
UFMylation: A Unique & Fashionable Modification for Life.
Genomics Proteomics Bioinformatics. 2016 Jun;14(3):140-146. doi: 10.1016/j.gpb.2016.04.001. Epub 2016 May 20.
7
Proximity biotinylation at the host- interface reveals UFMylation as an antibacterial pathway.
bioRxiv. 2025 May 29:2025.05.29.656827. doi: 10.1101/2025.05.29.656827.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
10
Pain management for women in labour: an overview of systematic reviews.
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD009234. doi: 10.1002/14651858.CD009234.pub2.

引用本文的文献

2
Post-Translational Modifications in Cilia and Ciliopathies.
Adv Sci (Weinh). 2025 Aug;12(31):e16562. doi: 10.1002/advs.202416562. Epub 2025 May 28.
3
The Nucleolus: A Central Hub for Ribosome Biogenesis and Cellular Regulatory Signals.
Int J Mol Sci. 2025 Apr 28;26(9):4174. doi: 10.3390/ijms26094174.

本文引用的文献

1
Targeted degradation of VEGF with bispecific aptamer-based LYTACs ameliorates pathological retinal angiogenesis.
Theranostics. 2024 Aug 19;14(13):4983-5000. doi: 10.7150/thno.98467. eCollection 2024.
2
The emerging roles of UFMylation in the modulation of immune responses.
Clin Transl Med. 2024 Sep;14(9):e70019. doi: 10.1002/ctm2.70019.
3
Eg5 UFMylation promotes spindle organization during mitosis.
Cell Death Dis. 2024 Jul 31;15(7):544. doi: 10.1038/s41419-024-06934-w.
5
UFMylation: An integral post-translational modification for the regulation of proteostasis and cellular functions.
Pharmacol Ther. 2024 Aug;260:108680. doi: 10.1016/j.pharmthera.2024.108680. Epub 2024 Jun 13.
6
Targeted protein degradation: from mechanisms to clinic.
Nat Rev Mol Cell Biol. 2024 Sep;25(9):740-757. doi: 10.1038/s41580-024-00729-9. Epub 2024 Apr 29.
7
PTIP UFMylation promotes replication fork degradation in BRCA1-deficient cells.
J Biol Chem. 2024 Jun;300(6):107312. doi: 10.1016/j.jbc.2024.107312. Epub 2024 Apr 22.
8
PARP1 UFMylation ensures the stability of stalled replication forks.
Proc Natl Acad Sci U S A. 2024 Apr 30;121(18):e2322520121. doi: 10.1073/pnas.2322520121. Epub 2024 Apr 24.
9
Human iPSC 4R tauopathy model uncovers modifiers of tau propagation.
Cell. 2024 May 9;187(10):2446-2464.e22. doi: 10.1016/j.cell.2024.03.015. Epub 2024 Apr 5.
10
Mono-UFMylation promotes misfolding-associated secretion of α-synuclein.
Sci Adv. 2024 Mar 15;10(11):eadk2542. doi: 10.1126/sciadv.adk2542.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验